Cardinal Health Inc (CAH) : Charter Research Investment Group reduced its stake in Cardinal Health Inc by 0.64% during the most recent quarter end. The investment management company now holds a total of 31,696 shares of Cardinal Health Inc which is valued at $2,649,786 after selling 205 shares in Cardinal Health Inc , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Cardinal Health Inc makes up approximately 2.97% of Charter Research Investment Group’s portfolio.
Other Hedge Funds, Including , Grantham Mayo Van Otterloo sold out all of its stake in CAH during the most recent quarter. The investment firm sold 4,800 shares of CAH which is valued $401,280.Commonwealth Of Pennsylvania Public School Empls Retrmt Sys boosted its stake in CAH in the latest quarter, The investment management firm added 1,648 additional shares and now holds a total of 26,087 shares of Cardinal Health Inc which is valued at $2,180,873. Cardinal Health Inc makes up approx 0.04% of Commonwealth Of Pennsylvania Public School Empls Retrmt Sys’s portfolio. Wafra Investment Advisory Group Inc Ny sold out all of its stake in CAH during the most recent quarter. The investment firm sold 37,261 shares of CAH which is valued $3,115,020.Sumitomo Mitsui Asset Management Company Ltd boosted its stake in CAH in the latest quarter, The investment management firm added 394 additional shares and now holds a total of 25,212 shares of Cardinal Health Inc which is valued at $2,107,723. Cardinal Health Inc makes up approx 0.06% of Sumitomo Mitsui Asset Management Company Ltd’s portfolio.Checchi Capital Advisers reduced its stake in CAH by selling 125 shares or 3.55% in the most recent quarter. The Hedge Fund company now holds 3,399 shares of CAH which is valued at $282,083. Cardinal Health Inc makes up approx 0.07% of Checchi Capital Advisers’s portfolio.
Cardinal Health Inc opened for trading at $79.38 and hit $79.89 on the upside on Monday, eventually ending the session at $79.77, with a gain of 0.53% or 0.42 points. The heightened volatility saw the trading volume jump to 14,26,982 shares. Company has a market cap of $25,414 M.
On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.
Investors should note that on Aug 8, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Sep 29, 2016 as the ex-dividend date and fixed the record date on Oct 3, 2016. The payable date has been fixed on Oct 15, 2016.
Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.
Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.